NCT07000591

Brief Summary

This randomized controlled study will be conducted with 96 epilepsy patients and their caregivers at Atatürk University Research Hospital between November 2024 and February 2026. Participants will be randomly assigned to experimental and control groups. The experimental group will receive neck massage based on Jean Watson's Human Caring Model three times a week for eight weeks. Data will be collected using various scales to evaluate self-efficacy, symptom management, and caregiver burden before and after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 3, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

June 15, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

October 1, 2025

Status Verified

May 1, 2025

Enrollment Period

Same day

First QC Date

May 24, 2025

Last Update Submit

September 26, 2025

Conditions

Keywords

EpilepsyHuman Caring ModelSelf-EfficacySymptom Management

Outcome Measures

Primary Outcomes (3)

  • Epilepsy Self-Efficacy Scale

    The Epilepsy Self-Efficacy Scale was originally developed by DiIorio et al. in 1992 as a 25-item tool to assess individuals' belief in their ability to manage their epilepsy. In 2000, 8 additional items were included in the original scale. The Turkish validity and reliability study was conducted in 2019 by Öznur Adadıoğlu. Cronbach's alpha values were reported as 0.88 for the management factor, 0.84 for the general management factor, 0.82 for illness and medication management, 0.55 for seizure management, and 0.91 for the total scale. Based on factor analysis, 2 items were removed, and the final Turkish version included 31 items. Items are scored from "0 - I cannot do at all" to "10 - I am absolutely sure I can do," and total scores range from 0 to 310. When averaged, scores range from 0 to 10. Higher scores indicate greater self-efficacy.

    four months

  • Zarit Burden Interview (ZBI)

    The Zarit Burden Interview was developed in 1980 by Zarit, Reever, and Bach-Peterson to assess the level of stress experienced by caregivers. It consists of 22 items addressing social and emotional aspects of caregiving. Each item is scored on a 5-point Likert scale ranging from "never" to "nearly always." Total scores range from 0 to 88, with higher scores indicating greater caregiver burden. Reliability studies found internal consistency coefficients between 0.87 and 0.94. The Turkish validity and reliability study was conducted by İnci in 2006, with a Cronbach's alpha of 0.95.

    four months

  • Epilepsy Symptom Management Scale

    This scale was developed by the researchers based on relevant literature (Kurt \& Ünsar, 2009; Yeşilbalkan et al., 2008; Yıldırım et al., 2011; Tülek et al., 2016; Mollaoğlu et al., 2015; Önsöz \& Usta Yeşilbalkan, 2013; Atay Turan et al., 2007) for use in a doctoral dissertation. Initially, 40 items were drafted. Following expert review, two items were removed, one was split into two, and six were revised, resulting in a final version with 39 items. The scale provides a holistic, user-friendly tool for epilepsy patients to self-assess all symptoms in a single form. Patients indicate whether they experienced symptoms in the past week (Yes/No). If "Yes," they rate the impact on a 5-point Likert scale: 1 = Not at all disturbing to 5 = Extremely disturbing. Total scores range from 0 to 195, with higher scores indicating greater symptom burden. To assess content validity, 10 experts evaluated each item using Davis' method, which involves rating items as: 1 = Not appropriate, 2 = Needs major

    four months

Study Arms (2)

Control Group

NO INTERVENTION

After the initial data is collected, no interventions other than routine nursing care will be applied to the patients and their caregivers. Not intervening in the control group will be necessary to accurately evaluate whether the research hypothesis is significant. This approach will ensure that only the effects of the intervention are isolated, allowing for a proper analysis of the differences between groups based on the research hypothesis. For this group, the researchers will administer the "Patient Introduction Form," the "Epilepsy Self-Efficacy Scale," and the "Epilepsy Symptom Management Scale" to the patients, and the "Caregiver Introduction Form" and the "Zarit Burden Interview" to the caregivers, as data collection tools, eight weeks after the initial assessment to collect the final test data.

Experimental group

EXPERIMENTAL

Patients will receive a neck massage based on Watson's Human Caring Model in addition to standard medical care. The massage will be performed three times a week for eight weeks, totaling 24 sessions. Sessions will last 30 minutes and follow evidence-based nursing interventions. Care will be individualized and delivered in a calming environment. Pre- and post-intervention assessments will include the Epilepsy Self-Efficacy Scale and the Epilepsy Symptom Management Scale for patients, and the Zarit Burden Interview for caregivers. Caregivers will also complete an introductory form. All data will be collected at baseline and after eight weeks. The massage's impact on both patient outcomes and caregiver burden will be evaluated.

Other: Experimental Group

Interventions

Patients will receive a neck massage based on Watson's Human Caring Model in addition to standard medical care. The massage will be performed three times a week for eight weeks, totaling 24 sessions. Sessions will last 30 minutes and follow evidence-based nursing interventions. Care will be individualized and delivered in a calming environment. Pre- and post-intervention assessments will include the Epilepsy Self-Efficacy Scale and the Epilepsy Symptom Management Scale for patients, and the Zarit Burden Interview for caregivers. Caregivers will also complete an introductory form. All data will be collected at baseline and after eight weeks. The massage's impact on both patient outcomes and caregiver burden will be evaluated.

Also known as: Treatment
Experimental group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 65 years,
  • Diagnosed with Generalized Tonic-Clonic Seizures or Focal Epilepsy,
  • Able to speak and understand Turkish,
  • Conscious and alert,
  • Able to communicate verbally,
  • No history of neck trauma,
  • No cervical disc herniation,
  • No severe headaches or migraines,
  • Not diagnosed with cancer,
  • No neurological and/or psychiatric disorders affecting cognitive function,
  • No acute (recently developed) health issues (e.g., heart attack, fainting),
  • No uncontrolled high blood pressure,
  • No use of analgesic medications in the past 24 hours,
  • No contraindications to massage therapy (e.g., advanced COPD, asthma, heart or kidney failure, malignant conditions, febrile illnesses, or pregnancy),
  • No skin issues (rash, redness, lesions, heat increase, swelling, edema, bone abnormalities, or localized infections) in the area where massage is to be applied.

You may not qualify if:

  • Declining to continue participation in the study,
  • Experiencing pain during massage application,
  • Changes in the pharmacological treatment regimen,
  • Failing to attend massage sessions,
  • Development of undesirable effects (e.g., bruising or discoloration) in the massage area, which leads to termination of sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk University

Erzurum, Erzurum, 25100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Epilepsy

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the study, blinding was not performed.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: In this clinical trial, Jean Watson's Human Caring Model will be used. The model provides a holistic and humane approach to care, addressing patients' physical, emotional, and spiritual needs. Interventions based on Watson's "Caring" approach aim to promote patient relaxation, build a sense of security, and improve quality of life. Thus, the healing effect of nursing care during the treatment process will be supported.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2025

First Posted

June 3, 2025

Study Start

June 15, 2025

Primary Completion

June 15, 2025

Study Completion

September 15, 2025

Last Updated

October 1, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations